Cancel
Victoria » Darebin city » Bundoora

Akaal Pharma Pty Ltd.

(No Reviews)
301 E & F, Thomas Cherry Building, Bundoora VIC 3086, Australia

Akaal Pharma Pty Ltd. is located in Darebin City of Victoria state. To communicate or ask something with the place, the Phone number is (03) 9479 2584. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Akaal Pharma Pty Ltd. quickly are -37.7207612 ,145.0470937

Contact and Address

Address: 301 E & F, Thomas Cherry Building, Bundoora VIC 3086, Australia
Postal code: 3086
Phone: (03) 9479 2584
Website: https://akaalpharma.com/

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Akaal Pharma Pty Ltd., use the form below and your opinion, advice or comment will appear in this space.

Write a Review

Photos of Akaal Pharma Pty Ltd.

Akaal Pharma Pty Ltd. | 301 E & F, Thomas Cherry Building, Bundoora VIC 3086, Australia | Phone: (03) 9479 2584
Akaal Pharma Pty Ltd. | 301 E & F, Thomas Cherry Building, Bundoora VIC 3086, Australia | Phone: (03) 9479 2584

Akaal Pharma Pty Ltd. On the Web

Akaal Pharma Pty Ltd Announces Licensing Agreement for its...

Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma's First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals).


Akaal Pharma, Australia extends collaboration with GVK BIO | GVK BIO

About Akaal Pharma: Akaal Pharma Pty Ltd (Akaal Pharma) is a clinical-stage drug discovery and development company Dale Dhanoa, Ph.D., CEO Akaal Pharma Pvt Ltd Phone: +1 858 925-4555 (San Diego, CA, USA), +61 3 9479 2584 (Melbourne, Australia) E-mail: info@akaalpharma.com.


Akaal Pharma Pty Ltd - Patent applications

12-29-2011. Patent applications by Akaal Pharma Pty Ltd.


Akaal Pharma Receives Approval to Initiate Phase 2 Clinical Trial for...

Akaal Pharma Pty Ltd, (Akaal Pharma), a clinical-stage biopharmaceutical company today announced the approval to initiate a randomized, double-blind +61 3 9479 2584 (Australia) info@akaalpharma.com.


Akaal pharma pty ltd Phone Number | Akaal pharma pty ltd Toll Free...

Akaal pharma pty ltd is a leading drug discovery company of Australia. Its drugs are used for treatment of autoimmune diseases and inflammation. The address of Akaal pharma pty ltd is 51 Yarcombe Crescent, Craigieburn Victoria 3064. data-ad-slot="7829909793">.


Akaal Pharma (@Akaal_Pharma) | Twitter

Viimeisimmät twiitit käyttäjältä Akaal Pharma (@Akaal_Pharma). Akaal Pharma is a clinical-stage drug discovery and development biopharmaceutical Akaal Pharma Pty Ltd. Thomas Cherry Building, #301 E & F Chemistry Department, La Trobe University, Bundoora, VIC - 3086, Australia.


Akaal Pharma Pty Ltd patents list (updated weekly)

Note: Akaal Pharma Pty Ltd may have other listings under different names/spellings. The compositions find use in the treatment of disease, particularly inflammation and immune mediated disorders.. ... Akaal Pharma Pty Ltd.


Akaal Pharma Pty Ltd patents in Australia

Akaal Pharma Pty Ltd is one of thousands of patent owners that we feature on IP in Australia which contains details of the over 1 million patents registered in Australia. We provide this information to help Australians with their research in the intellectual property space but to also help inventors (first time or...


Akaal Pharma Pty Ltd Announces Licensing... - MarketWatch

Akaal Pharma Pty Limited (Akaal Pharma) today announced that it has entered into a licensing agreement for Akaal Pharma's First-in-Class, topical Spingosine-1-Phosphate-1 (S1P1) modulator, AKP-11, with Boston Pharmaceuticals, Inc. (Boston Pharmaceuticals).


Bal Pharma News: Bal Pharma News, Results, Updates... - NDTV

Bal Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 2018 2. Consolidated Bal Pharma Limited has informed the Exchange regarding a press release dated March 06, 2018, titled " AKAAL PHARMA PTY LTD AND BAL PHARMA LTD TO DEVEL...